Bay-Area PH Professionals To Present at Wellness Expo
Hear from leading PH experts at PHA’s PH Wellness Expo in San Francisco, with exhibits, advocacy sessions and family fun.
In the News
Discover the latest news from the Pulmonary Hypertension, including advocacy updates, research articles and event coverage.
Recent news
Dislaying 1 — 6 of 399
-
-
New Pathlight: the Power of Music and More InspirationThe new issue of Pathlight is here. Explore inspiring stories in PHA’s quarterly magazine, available online and by mail.
News
-
Wildfire Smoke and PH: ‘Like Elephants on My Chest’People with pulmonary hypertension face greater risks from air pollution. Learn symptoms, risks and prevention tips.
News
-
What You Need To Know About Medicaid ChangesNew Medicaid work requirements take effect in 2027 in most states. See who may need to comply to keep coverage.
Insurance & treatment access | News
-
Professional Member Benefits To Change in 2027Learn about PHA's membership changes: beginning Jan. 1, 2027, key resources will be accessible only to PHA members.
News
-
Professionals: Earn Credit With 19 New Online CoursesEarn up to 20.25 CE/CME credits with 19 new PHA Online University courses, including recordings from the PHA 2026 Conference.
Education | News
PH in the News
-
Pulmovant opens Phase 3 mosliciguat study
Pulmovant is enrolling participants in its Phase 3 mosliciguat study after positive Phase 2 results.
-
FDA to review Ralinepag
The FDA will review United Therapeutic’s new drug application for Ralinepag, a once-daily pill to treat PAH.
-
Phase 1 trial shows treprostinil skin patch’s potential
Study suggests transdermal delivery could be alternative to existing treprostinil administration methods.